Browsing by Author Byrne, Jennifer

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 48  next >
Issue DateTitleAuthor(s)Citation
2003Alternative splicing as a mechanism for regulating 14-3-3 binding: interactions between hD53 (TPD52L1) and 14-3-3 proteinsBoutros, Rose; Byrne, Jennifer; Bailey, Angela M; Wilson, Sarah H D; Children's Hospital Westmead: Childrens Medical Research Ins; Children's Hospital Westmead: Paediatrics & Child HealthAlternative splicing as a mechanism for regulating 14-3-3 binding: interactions between hD53 (TPD52L1) and 14-3-3 proteins, Journal of Molecular Biology, vol.332,(3),2003,pp 675-687
2016The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugsByrne, Jennifer; Codd, Rachel; Telfer, Thomas; Atmadibrata, B; et al, Various; Guo, Su T.; Liu, Pei Y.; McCarroll, Joshua A.; Siddiqi, Faraz; Sokolowski, Nicolas; Sun, Yuting; Yu, Denise; Zhang, Lihong; Childrens Hospital Westmead: Paediatrics & Child Health; School of Medical Sciences: Pharmacology; School of Medical Sciences: PharmacologyThe BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugs, Oncotarget, vol.7, 48, 2016,pp 79217-79232
2015Biobank classification in an Australian settingByrne, Jennifer; Christiansen, Jeffrey H; Farrell, Jake P; Goode, Susan; Rush, Amanda; Scott, Rodney; Spring, K; Childrens Hospital Westmead: Paediatrics & Child HealthBiobank classification in an Australian setting, Biopreservation and Biobanking, vol.13, 3, 2015,pp 212-218
2012Challenges in Identifying Candidate Amplification Targets in Human Cancers: Chromosome 8q21 as a Case StudyByrne, Jennifer; Martin La Rotta, Nancy; Chen, Yuyan; Peters, Greg; Children's Hospital Westmead: Paediatrics & Child Health; Children's Hospital Westmead: Childrens Medical Research InsChallenges in Identifying Candidate Amplification Targets in Human Cancers: Chromosome 8q21 as a Case Study, Genes and Cancer, vol.3, 2, 2012,pp 87-101
2015A critical analysis of cancer biobank practices in relation to biospecimen qualityByrne, Jennifer; Rush, Amanda; Spring, K; Childrens Hospital Westmead: Paediatrics & Child HealthA critical analysis of cancer biobank practices in relation to biospecimen quality, Biophysical Reviews, vol.7, 4, 2015,pp 369-378
2005D53 (TPD52L1) is a cell cycle-regulated protein maximally expressed at the G2-M transition in breast cancer cells.Boutros, R; Byrne, Jennifer; Children's Hospital Westmead: Childrens Medical Research Ins; Children's Hospital Westmead: Paediatrics & Child HealthD53 (TPD52L1) is a cell cycle-regulated protein maximally expressed at the G2-M transition in breast cancer cells., Experimental Cell Research, vol.310,(1),2005,pp 152-165
2016Development and Validation of a High Pressure Liquid Chromatography-UV Method for the Determination of Treosulfan and Its Epoxy Metabolites in Human Plasma and Its Application in Pharmacokinetic StudiesByrne, Jennifer; Earl, John; Koyyalamudi, Sundar; Shaw, Peter; Fraser, Chris; Kuzhiumparambil, Unnikrishnan; Nath, Christa E.; O'Brien, Tracey; Childrens Hospital Westmead: Paediatrics & Child Health; Childrens Hospital Westmead: Paediatrics & Child Health; Childrens Hospital Westmead: Paediatrics & Child Health; Childrens Hospital Westmead: Paediatrics & Child HealthDevelopment and Validation of a High Pressure Liquid Chromatography-UV Method for the Determination of Treosulfan and Its Epoxy Metabolites in Human Plasma and Its Application in Pharmacokinetic Studies, Journal of Chromatographic Science, vol.54, 3, 2016,pp 326-333
2016Dropping in on the lipid droplet- tumor protein D52 (TPD52) as a new regulator and resident proteinByrne, Jennifer; Chen, Yuyan; Frost, Sarah; Childrens Hospital Westmead: Paediatrics & Child Health; Childrens Hospital Westmead: Paediatrics & Child Health; Childrens Hospital Westmead: Paediatrics & Child HealthDropping in on the lipid droplet- tumor protein D52 (TPD52) as a new regulator and resident protein, Adipocyte, vol.5, 3, 2016,pp 326-332
2006Expression of tumor protein D52-like genes in childhood leukemia at diagnosis: Clinical and sample considerations.Barbaric, Draga; Byrne, Jennifer; Byth, Karen; Dalla-Pozza, Luciano; Western Clinical School: Medicine (Westmead); Children's Hospital Westmead: Paediatrics & Child Health; School of Public Health: NH&MRC Clinical Trials Centre; Children's Hospital Westmead: Childrens Medical Research InsExpression of tumor protein D52-like genes in childhood leukemia at diagnosis: Clinical and sample considerations., Leukemia research, vol.30,(11),2006,pp 1355-1363
2010The formin INF2 regulates basolateral-to-apical transcytosis and lumen formation in association with Cdc42 and MAL2Byrne, Jennifer; Fanayan, Susan; Shahheydari, Hamideh; Shehata, Mona; Alonso, Miguel A.; Andres-Delgado, Laura; Aranda, Juan F.; Gomez, Sergio; Jimenez, Alberto; Madrid, Ricardo; Martin-Belmonte, Fernando; Rodriguez-Fraticelli, Alejo E.; Ventimiglia, Leandro; Children's Hospital Westmead: Paediatrics & Child Health; Northern Clinical School: Kolling Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead)The formin INF2 regulates basolateral-to-apical transcytosis and lumen formation in association with Cdc42 and MAL2, Developmental Cell, vol.18, 5,pp 814-827
2010Formin INF2 regulates MAL-mediated transport of Lck to the plasma membrane of human T lymphocytesByrne, Jennifer; Alonso, Miguel A.; Andres-Delgado, Laura; Anton, Olga M.; Madrid, Ricardo; Children's Hospital Westmead: Paediatrics & Child HealthFormin INF2 regulates MAL-mediated transport of Lck to the plasma membrane of human T lymphocytes, Blood, vol.116, 26,pp 5919-5929
2015Genetic causes of cancer predisposition in children and adolescentsByrne, Jennifer; Dalla-Pozza, Luciano; Saletta, Federica; Childrens Hospital Westmead: Paediatrics & Child Health; Children's Hospital Westmead: Childrens Medical Research Ins; School of Medical Sciences: PathologyGenetic causes of cancer predisposition in children and adolescents, Translational Pediatrics, vol.4, 2, 2015,pp 65-66
2017An HPLC-UV method for determining plasma dimethylacetamide concentrations in patients receiving intravenous busulfanByrne, Jennifer; Earl, John; Nath, Christa; Shaw, Peter; Upadhyay, Parth; Cendana, M; Lee, Samiuela; Childrens Hospital Westmead: Paediatrics & Child Health; Childrens Hospital Westmead: Paediatrics & Child Health; Pharmacy; Childrens Hospital Westmead: Paediatrics & Child Health; PharmacyAn HPLC-UV method for determining plasma dimethylacetamide concentrations in patients receiving intravenous busulfan, Biomedical Chromatography, vol.31, 7, 2017,pp 1-3
2014Identification of PLP2 and RAB5C as novel TPD52 binding partners through yeast two-hybrid screeningByrne, Jennifer; Chen, Yuyan; Frost, Sarah; Shahheydari, Hamideh; Groblewski, Guy E.; Smith, Brian; Childrens Hospital Westmead: Paediatrics & Child Health; Childrens Hospital Westmead: Paediatrics & Child Health; Childrens Hospital Westmead: Paediatrics & Child Health; Childrens Hospital Westmead: Paediatrics & Child HealthIdentification of PLP2 and RAB5C as novel TPD52 binding partners through yeast two-hybrid screening, Molecular Biology Reports, vol.41, 7, 2014,pp 4565-4572
2007Induction of tumorigenesis and metastasis by the murine orthologue of tumor protein D52Byrne, Jennifer; Bright, Robert K; Lewis, Jennifer; Payton, Laura; Smith, David I; Whitford, Jill; Yang, LiBang; Children's Hospital Westmead: Paediatrics & Child HealthInduction of tumorigenesis and metastasis by the murine orthologue of tumor protein D52, Molecular Cancer Research, vol.5,(2),2007,pp 133-144
2013Injection site and regulatory T cells influence durable vaccine-induced tumor immunity to an over-expressed self tumor associated antigenByrne, Jennifer; Bright, Jennifer D; Bright, Robert K; Schultz, Heather N; Children's Hospital Westmead: Paediatrics & Child HealthInjection site and regulatory T cells influence durable vaccine-induced tumor immunity to an over-expressed self tumor associated antigen, OncoImmunology, vol.2, 7, 2013,pp 1-11
2010Interaction between urokinase receptor and heat shock protein MRJ enhances cell adhesionByrne, Jennifer; Lin, Zhen (Mike); de Bock, Charles Edo; Mekkawy, Ahmed H.; Wang, Yao; Children's Hospital Westmead: Paediatrics & Child Health; Northern Clinical School: Kolling InstituteInteraction between urokinase receptor and heat shock protein MRJ enhances cell adhesion, International Journal of Oncology, vol.36, 5,pp 1155-1163
2002The LIM doman protein LM04 interacts with the cofactor CtIP and the tumour suppressor BRCA1 and inhibits BRCA1 activityByrne, Jennifer; Chen, Junjie; Lindeman, Geoffrey J.; Peng, Benjamin; Sum, Eleanor Y M; Visvader, Jane E; Yu, Xin; Children's Hospital Westmead: Paediatrics & Child HealthThe LIM doman protein LM04 interacts with the cofactor CtIP and the tumour suppressor BRCA1 and inhibits BRCA1 activity, Journal of Biological Chemistry, vol.277,(10),2002,pp 7849-7856
2014Lipidomics in breast cancerByrne, Jennifer; Kamili, Alvin; Childrens Hospital Westmead: Paediatrics & Child HealthLipidomics in breast cancer in Omics Approaches in Breast Cancer: Towards Next-Generation Diagnosis, Prognosis and Therapy, Springer, 2014, pp. 225-244
2010MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcomeByrne, Jennifer; deFazio, Anna; Emmanuel, Catherine; Fanayan, Susan; Murali, Rajmohan; Gloss, B; Hacker, Neville F.; Hardy, Jayne; Maleki, Sanaz; O'Brien, Philippa M.; Scurry, James P.; Sutherland, Robert L.; Children's Hospital Westmead: Paediatrics & Child Health; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Northern Clinical School: Kolling Institute; Central Clinical School: PathologyMAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome, BMC Cancer, vol.10, 497,pp 1-11